India
Indian authorities say J&J’s baby shampoo contains ‘harmful ingredients’
April 1, 2019Sales and Marketing Cancer, India, J&J, JJ, Johnson & Johnson, Rajasthan, baby shampoo, formaldehyde
Indian authorities in the state of Rajasthan have said that samples taken from Johnson & Johnson’s baby shampoo contained ‘harmful …
Indian measles vaccination campaign saved tens of thousands of lives
March 6, 2019Research and Development Asia, India, South Asia, infectious diseases, measles, vaccines
A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a …
Indian government set to colour code generic medicines
March 4, 2019Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales
As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …
Just 10% of those harmed in clinical trials in India receive compensation
January 21, 2019Sales and Marketing India, WHO, clinical trials, compensation, health
Clinical trials have led to nearly 5,000 deaths in India since 2005, while just a fraction of those affected have …
Sun Pharma’s shares hit six-year low after further whistleblower allegations emerge
January 18, 2019Medical Communications India, Sun Pharma, pharma
Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …
Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk
January 9, 2019Manufacturing and Production, Research and Development India, Pfizer, pharma
Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …
J&J’s Baby powder tested in India and Bangladesh
December 21, 2018Medical Communications Bangladesh, Cancer, India, J&J, JJ, asbestos
Bangladeshi authorities will collect and test samples of Johnson & Johnson’s baby powders for traces of cancer causing asbestos, after …
Indian authorities seize J&J Baby Powder in response to Reuters report
December 19, 2018Research and Development Cancer, India, J&J, JJ, asbestos, baby powder, regulation
Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after …
India declares Sterling Biotech owners ‘Economic Fugitives’
October 26, 2018Medical Communications India, Modi, Sandesara, Sterling Biotech, corruption
India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new powers …
Top Ten most popular articles on Pharmafile.com this week
August 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10
As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …
Blockchain deployed in fight against fake pharmaceuticals in India
August 22, 2018Research and Development India, NITI, blockchain, pharma, technology
Indian policymakers in collaboration with an Indian hospital chain and an American multinational, have initiated plans to deploy blockchain technology …
Indian biotech owner detained in Dubai over £550m fraud allegations
August 16, 2018Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud
Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …
Wockhardt launches $40m manufacturing plant in Dubai
July 30, 2018Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma
Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …
China opens market to Indian drugs with reduced tariffs
July 10, 2018Manufacturing and Production, Sales and Marketing China, India, pharma
India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …
AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer
June 22, 2018Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma
In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
